Filter Search


Healthcare and Medical


Location Summary Deadline
Germany Provision Of A Non-exclusive Discount Agreement For The Active Ingredient Fentanyl Through An Open-house Model. Fentanyl 2028-01-31
Germany Conclusion Not Excluding The Discount Agreement For Pharmaceuticals According To § 130a Para. 8 Sgb V By Means Of An Open House Model For The Active Ingredient Fentanyl (atc Code According To Who 2028-01-31
Germany Open House Pharmaceutical Discount Contracts For The Active Ingredient Adalimumab, Atc L04ab04 2028-01-31
Germany Open House Pharmaceutical Discount Contracts For The Active Ingredient Infliximab, Atc L04ab02 2028-01-31
Germany The Subject Of This Publication Is The Conclusion Of Non-exclusive Discount Agreements According To § 130a Abs. 8 Sgb V For Medicines Containing The Active Ingredient Fentanyl (atc Code According To Who: N02ab03), Limited To The Dosage Forms Of Sublingual 2028-02-01
Germany Conclusion Not Excluding The Discount Agreement For Pharmaceuticals According To § 130a Para. 8 Sgb V By Means Of An Open House Model For The Active Ingredient Umeclidinium (atc Code According To Who 2028-02-29
Germany Conclusion Of A Non-exclusive Discount Agreement According To § 130a Para. 8 Sgb V For The Active Ingredient Trientine (exclusively Dosage Form Fta), Atc A16ax12 For The Period 01.05.2630.04.28 2028-03-05
Bangladesh This Is An Invalid Tender.this Is Used To Explain Corrigendum Process In Egp System. 2028-03-20
Germany Conclusion Of A Non-exclusive Discount Agreement In Accordance With Section 130a Paragraph 8 Sgb V For Medicines With The Active Ingredient Leuprorelin (atc Code: L02ae02). 2028-03-27
Germany Conclusion Of A Non-exclusive Discount Agreement According To § 130a Para. 8 Sgb V For Pharmaceuticals Containing The Active Ingredient Leuprolide (atc Code 2028-03-27
Whats app